Elevance Health (ELV) Price to Earnings (2009 - 2026)

Elevance Health (ELV) has reported Price to Earnings for 18 consecutive years, with 57.67 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Price to Earnings rose 15.02% year-over-year to 57.67 in Q2 2026; TTM through Jun 2026 was 16.95, a 3.68% increase from a year earlier, with the FY2025 full-year figure at 13.67, down 2.75% from the prior year.
• Price to Earnings was 57.67 for Q2 2026 at Elevance Health, up from 36.16 in the prior quarter.
• Over five years, Price to Earnings peaked at 203.19 in Q4 2024 and troughed at 36.16 in Q1 2026.
• A 5-year average of 82.7 and a median of 63.51 in 2022 frame the typical range for Price to Earnings.
• Across the five-year window, Price to Earnings surged 53.63% in 2024 and slumped 49.48% in 2025, its largest moves.
• Over 5 years, Price to Earnings stood at 139.19 in 2022, then fell by 4.98% to 132.26 in 2023, then soared by 53.63% to 203.19 in 2024, then slumped by 30.26% to 141.71 in 2025, then sank by 59.3% to 57.67 in 2026.
• The last three Price to Earnings figures came in at 57.67 (Q2 2026), 36.16 (Q1 2026), and 141.71 (Q4 2025), per Business Quant data.